Kangmei Pharma | 600518 - Fremdkapital

Aktienkurs
1.65
Täglich Wechseln
-0.04 -2.37%
Monatlich
-6.78%
Jährlich
-15.82%
Q2 Prognose
1.67




Fremdkapital Veränderung Datum
Akebia Therapeutics USD 36.39M 11.85M 2026-03
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Avita Medical AUD 42.24M 1.25M 2024-12
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Dianthus Therapeutics USD 0 0 2024-12
Genomma Lab Internacional MXN 4.73B 67.16M 2026-03
Hypermarcas BRL 8.11B 551.86M 2025-12
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
IQVIA Holdings USD 13.99B 105M 2026-03
Jiangsu Hengrui CNY 37.1M 6.2M 2026-03
Kangmei Pharma CNY 78.45M 5.8M 2025-09
Moderna USD 603M 7M 2026-03
Organon & Co USD 8.55B 75M 2026-03
Revvity USD 2.63B 836K 2026-03
Sh Fosun Pharma CNY 15.95B 562.19M 2026-03
Tectonic Therapeutic USD 43K 57K 2025-12
Viatris USD 12.41B 67.1M 2026-03
Wuxi Apptec CNY 1.82B 455.56M 2026-03
Xeris Pharmaceuticals USD 221.22M 889K 2026-03
Zz Pientze Pharmaceu CNY 182.29M 4.27M 2026-03